489 related articles for article (PubMed ID: 19703304)
1. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.
van der Heijde D; Salonen D; Weissman BN; Landewé R; Maksymowych WP; Kupper H; Ballal S; Gibson E; Wong R; ;
Arthritis Res Ther; 2009; 11(4):R127. PubMed ID: 19703304
[TBL] [Abstract][Full Text] [Related]
2. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.
van der Heijde D; Landewé R; Baraliakos X; Houben H; van Tubergen A; Williamson P; Xu W; Baker D; Goldstein N; Braun J;
Arthritis Rheum; 2008 Oct; 58(10):3063-70. PubMed ID: 18821688
[TBL] [Abstract][Full Text] [Related]
3. Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab.
Braun J; Baraliakos X; Hermann KG; Xu S; Hsu B
J Rheumatol; 2016 Sep; 43(9):1704-12. PubMed ID: 27422890
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS).
Baraliakos X; Østergaard M; Gensler LS; Poddubnyy D; Lee EY; Kiltz U; Martin R; Sawata H; Readie A; Porter B;
Clin Drug Investig; 2020 Mar; 40(3):269-278. PubMed ID: 31983056
[TBL] [Abstract][Full Text] [Related]
5. Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab.
Baraliakos X; Listing J; Brandt J; Haibel H; Rudwaleit M; Sieper J; Braun J
Rheumatology (Oxford); 2007 Sep; 46(9):1450-3. PubMed ID: 17623745
[TBL] [Abstract][Full Text] [Related]
6. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.
van der Heijde D; Landewé R; Einstein S; Ory P; Vosse D; Ni L; Lin SL; Tsuji W; Davis JC
Arthritis Rheum; 2008 May; 58(5):1324-31. PubMed ID: 18438853
[TBL] [Abstract][Full Text] [Related]
7. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
[TBL] [Abstract][Full Text] [Related]
8. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
Ramiro S; van der Heijde D; van Tubergen A; Stolwijk C; Dougados M; van den Bosch F; Landewé R
Ann Rheum Dis; 2014 Aug; 73(8):1455-61. PubMed ID: 24812292
[TBL] [Abstract][Full Text] [Related]
9. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.
Baraliakos X; Haibel H; Listing J; Sieper J; Braun J
Ann Rheum Dis; 2014 Apr; 73(4):710-5. PubMed ID: 23505240
[TBL] [Abstract][Full Text] [Related]
10. Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab.
Baraliakos X; Listing J; Rudwaleit M; Brandt J; Sieper J; Braun J
Ann Rheum Dis; 2005 Oct; 64(10):1462-6. PubMed ID: 15778240
[TBL] [Abstract][Full Text] [Related]
11. Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Ramiro S; van Tubergen A; Stolwijk C; Landewé R; van de Bosch F; Dougados M; van der Heijde D
Arthritis Res Ther; 2013 Jan; 15(1):R14. PubMed ID: 23327723
[TBL] [Abstract][Full Text] [Related]
12. Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.
Maas F; Arends S; Brouwer E; Essers I; van der Veer E; Efde M; van Ooijen PMA; Wolf R; Veeger NJGM; Bootsma H; Wink FR; Spoorenberg A
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1011-1019. PubMed ID: 27696754
[TBL] [Abstract][Full Text] [Related]
13. Baseline extent of damage predicts spinal radiographic progression in Korean patients with ankylosing spondylitis treated with golimumab.
Lee JS; Song YW; Kim TH; Chung WT; Lee SG; Park SH; Song GG; Yu DY; Xu S; Lee EY
Korean J Intern Med; 2018 May; 33(3):622-628. PubMed ID: 28103433
[TBL] [Abstract][Full Text] [Related]
14. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study.
Ramiro S; Stolwijk C; van Tubergen A; van der Heijde D; Dougados M; van den Bosch F; Landewé R
Ann Rheum Dis; 2015 Jan; 74(1):52-9. PubMed ID: 23956249
[TBL] [Abstract][Full Text] [Related]
15. Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.
Park JW; Kim MJ; Lee JS; Ha YJ; Park JK; Kang EH; Lee YJ; Song YW; Lee EY
Arthritis Rheumatol; 2019 Jan; 71(1):82-90. PubMed ID: 29984487
[TBL] [Abstract][Full Text] [Related]
16. The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.
Haroon N; Inman RD; Learch TJ; Weisman MH; Lee M; Rahbar MH; Ward MM; Reveille JD; Gensler LS
Arthritis Rheum; 2013 Oct; 65(10):2645-54. PubMed ID: 23818109
[TBL] [Abstract][Full Text] [Related]
17. Incorporating assessment of the cervical facet joints in the modified Stoke ankylosing spondylitis spine score is of additional value in the evaluation of spinal radiographic outcome in ankylosing spondylitis.
Maas F; Arends S; Brouwer E; Bootsma H; Bos R; Wink FR; Spoorenberg A
Arthritis Res Ther; 2017 Apr; 19(1):77. PubMed ID: 28441960
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of the anteroposterior lumbar radiographs in the modified Stoke Ankylosing Spondylitis Spine Score improves detection of radiographic spinal progression in axial spondyloarthritis.
Llop M; Rios Rodriguez V; Redeker I; Sieper J; Haibel H; Rudwaleit M; Poddubnyy D
Arthritis Res Ther; 2019 May; 21(1):126. PubMed ID: 31126334
[TBL] [Abstract][Full Text] [Related]
19. Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor.
Pedersen SJ; Weber U; Said-Nahal R; Sørensen IJ; Loft AG; Kollerup G; Juul L; Frandsen PB; Thamsborg G; Madsen OR; Møller J; Balding L; Jurik AG; Østergaard M
Scand J Rheumatol; 2019 May; 48(3):185-197. PubMed ID: 30422733
[TBL] [Abstract][Full Text] [Related]
20. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis.
Machado P; Landewé R; Braun J; Hermann KG; Baker D; van der Heijde D
Ann Rheum Dis; 2010 Aug; 69(8):1465-70. PubMed ID: 20498215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
